ConductScience.org, home

Paper28539619

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.

Hansen TF and 4 others. Sci Rep, 2017. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. Papers, record 28539619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28539619

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab.
PubMed
Journal
Sci Rep
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2020-12-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hansen TFTorben Frøstrup
2Andersen RFRikke Fredslund
3Olsen DADorte Aalund
4Sørensen FBFlemming Brandt
5Jakobsen AAnders

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
BevacizumabMajor topic
Biomarkers, TumorMajor topic
Colorectal NeoplasmsMajor topic
Endothelial Growth FactorsMajor topic
Polymorphism, Single NucleotideMajor topic
Adult
Aged
Calcium-Binding Proteins
Capecitabine
EGF Family of Proteins
Female
Humans
Lymphatic Metastasis
Male
Middle Aged
Oxaliplatin
Prognosis
Prospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121407216Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer.Br J Cancer2011https://conductscience.org/library/papers/21407216PubMed
221433001Biospecimen reporting for improved study quality (BRISQ).Cancer Cytopathol2011https://conductscience.org/library/papers/21433001PubMed
315162510Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells.Dev Dyn2004https://conductscience.org/library/papers/15162510PubMed
423945239Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.J Clin Invest2013https://conductscience.org/library/papers/23945239PubMed
525113767Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.J Clin Oncol2014https://conductscience.org/library/papers/25113767PubMed
623386126EGFL7 ligates αvβ3 integrin to enhance vessel formation.Blood2013https://conductscience.org/library/papers/23386126PubMed
716106245REporting recommendations for tumour MARKer prognostic studies (REMARK).Br J Cancer2005https://conductscience.org/library/papers/16106245PubMed
817934064Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death.Am J Physiol Lung Cell Mol Physiol2008https://conductscience.org/library/papers/17934064PubMed
914592969VE-statin, an endothelial repressor of smooth muscle cell migration.EMBO J2003https://conductscience.org/library/papers/14592969PubMed
1022139032
The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.
Int J Colorectal Dis2012https://conductscience.org/library/papers/22139032PubMed
1117626061EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.Development2007https://conductscience.org/library/papers/17626061PubMed
1219097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1325584492Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.Br J Cancer2015https://conductscience.org/library/papers/25584492PubMed
1425308363Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer.Hepatobiliary Pancreat Dis Int2014https://conductscience.org/library/papers/25308363PubMed
1515085134The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation.Nature2004https://conductscience.org/library/papers/15085134PubMed
1623669226Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.J Clin Oncol2013https://conductscience.org/library/papers/23669226PubMed
1723922111MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial.Br J Cancer2013https://conductscience.org/library/papers/23922111PubMed
1815972971EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury.Am J Pathol2005https://conductscience.org/library/papers/15972971PubMed
1925140000Epidermal growth factor-like domain 7 predicts response to first-line chemotherapy and bevacizumab in patients with metastatic colorectal cancer.Mol Cancer Ther2014https://conductscience.org/library/papers/25140000PubMed
2023558933The expression of Egfl7 in human normal tissues and epithelial tumors.Int J Biol Markers2013https://conductscience.org/library/papers/23558933PubMed

See all 26 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
41859310The Association of EGFL7 Polymorphism and Expression with Cervical Cancer Susceptibility and Pathogenesis.Int J Gen Med2026https://conductscience.org/library/papers/41859310PubMed
38790260Elucidating Cancer Subtypes by Using the Relationship between DNA Methylation and Gene Expression.Genes (Basel)2024https://conductscience.org/library/papers/38790260PubMed
37957249Low EGFL7 expression is associated with high lymph node spread and invasion of lymphatic vessels in colorectal cancer.Sci Rep2023https://conductscience.org/library/papers/37957249PubMed
35698739EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome.J Pathol Transl Med2022https://conductscience.org/library/papers/35698739PubMed
35494025The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility.Front Oncol2022https://conductscience.org/library/papers/35494025PubMed
34217251Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma.BMC Cancer2021https://conductscience.org/library/papers/34217251PubMed
34017420Epidermal growth factor-like domain 7 regulates breast cancer cell proliferation and vascular endothelial growth factor expression via the p38MAPK signaling pathway.Am J Transl Res2021https://conductscience.org/library/papers/34017420PubMed
33917022Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview.Int J Mol Sci2021https://conductscience.org/library/papers/33917022PubMed
33635474EGFL7 as a novel therapeutic candidate regulates cell invasion and anoikis in colorectal cancer through PI3K/AKT signaling pathway.Int J Clin Oncol2021https://conductscience.org/library/papers/33635474PubMed
31824558The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer.Front Genet2019https://conductscience.org/library/papers/31824558PubMed
31245291microRNA-126 Is a Tumor Suppressor of Granulosa Cell Tumor Mediated by Its Host Gene EGFL7.Front Oncol2019https://conductscience.org/library/papers/31245291PubMed
30561001Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.Int J Cancer2019https://conductscience.org/library/papers/30561001PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28539619

GET https://conductscience.org/api/papers/v1/28539619/references?page=2